Q4 2024 Holdings
Filed 2025-02-14 | 33 holdings | $457.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Becton Dickinson & Co(BDX) | COM | 075887109 | $33.7M | 148,615 | 7.4% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $29.7M | 215,587 | 6.5% |
| Bristol-Myers Squibb Co(BMY) | COM | 110122108 | $28.2M | 499,151 | 6.2% |
| Springworks Therapeutics Inc | COM | 85205L107 | $27.6M | 764,668 | 6.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $24.8M | 284,654 | 5.4% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $24.7M | 333,144 | 5.4% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $24.7M | 898,458 | 5.4% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $23.7M | 512,447 | 5.2% |
| Septerna Inc(SEPN) | COM | 81734D104 | $23.5M | 1,024,245 | 5.1% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $21.5M | 457,587 | 4.7% |
| Envista Holdings Corporation(NVST) | COM | 29415F104 | $19.7M | 1,019,529 | 4.3% |
| Veracyte Inc(VCYT) | COM | 92337F107 | $19.4M | 490,547 | 4.2% |
| Intuitive Surgical Inc(ISRG) | COM NEW | 46120E602 | $19.3M | 36,910 | 4.2% |
| Exact Sciences Corp(EXAS) | COM | 30063P105 | $17.4M | 309,103 | 3.8% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $16.6M | 763,471 | 3.6% |
| Uniqure NV(QURE) | SHS | N90064101 | $15.9M | 901,973 | 3.5% |
| Structure Therapeutics Inc(GPCR) | SPONSORED ADS | 86366E106 | $15.4M | 569,395 | 3.4% |
| Masimo Corp(MASI) | COM | 574795100 | $14.4M | 87,377 | 3.2% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $11.4M | 179,815 | 2.5% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $8.8M | 512,724 | 1.9% |
| Inari MED Inc(NARIUSD) | COM | 45332Y109 | $6.8M | 132,545 | 1.5% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $6.5M | 72,925 | 1.4% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $6.4M | 407,292 | 1.4% |
| Protara Therapeutics Inc(TARA) | COM STK | 74365U107 | $5.7M | 1,088,691 | 1.3% |
| Mersana Therapeutics Inc | COM | 59045L106 | $2.4M | 1,705,036 | 0.5% |
| Kyverna Therapeutics Inc(KYTX) | COM | 501976104 | $2.2M | 586,909 | 0.5% |
| Metagenomi Inc(MGX) | COM | 59102M104 | $1.9M | 528,993 | 0.4% |
| Karyopharm Therapeutics Inc(KPTIEUR) | COM | 48576U106 | $1.6M | 2,334,375 | 0.3% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $1.5M | 187,184 | 0.3% |
| Hyperfine Inc(HYPR) | COM CL A | 44916K106 | $668.8K | 760,035 | 0.1% |
| Fractyl Health Inc(GUTS) | COM | 35168W103 | $441.3K | 214,236 | 0.1% |
| Atai Life Sciences NV | SHS | N0731H103 | $261.8K | 196,858 | 0.1% |
| Sensei Biotherapeutics Inc | COM | 81728A108 | $144.3K | 294,374 | 0.0% |